Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 19, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/20/2625    most recent
ddg283v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Iwata, A.
Right arrow Articles by Nukina, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwata, A.
Right arrow Articles by Nukina, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 20 2625-2635
DOI: 10.1093/hmg/ddg283
© 2003 Oxford University Press

Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies

Atsushi Iwata1,2, Mieko Maruyama1, Takumi Akagi3, Tsutomu Hashikawa3, Ichiro Kanazawa4, Shoji Tsuji2 and Nobuyuki Nukina1,*

1Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, 2-1 Hirosawa Wako-shi, Saitama 351-0198, Japan, 2Department of Neurology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo Bunkyo-ku, Tokyo 113-8655, Japan, 3Laboratory for Neural Architecture, RIKEN Brain Science Institute, 2-1 Hirosawa Wako-shi, Saitama 351-0198, Japan and 4National Center for Psychiatry and Neurology, 4-1-1 Ogawahigashi-cho Kodaira-shi, Tokyo 187-8551, Japan

Received June 2, 2003; Revised July 31, 2003; Accepted August 13, 2003

Accumulation of insoluble alpha-synuclein aggregates in the brain is characteristic of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Although numerous studies on the aggregation properties of alpha-synuclein have been reported, little is known about its degradation so far. In view of proteolytic degradation, we have found that the serine protease neurosin (kallikrein-6) degrades alpha-synuclein and co-localizes with pathological inclusions such as Lewy bodies and glial cytoplasmic inclusions. In vitro study showed that neurosin prevented alpha-synuclein polymerization by reducing the amount of monomer and also by generating fragmented alpha-synucleins that themselves inhibited the polymerization. Upon cellular stress, neurosin was released from mitochondria to the cytosol, which resulted in the increase of degraded alpha-synuclein species. Down-regulation of neurosin caused accumulation of alpha-synuclein within cultured cells. Thus we concluded that neurosin plays a significant role in physiological alpha-synuclein degradation and also in the pathogenesis of synucleinopathies.

* To whom correspondence should be addressed. Email: nukina{at}brain.riken.go.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
G. Sotiropoulou, G. Pampalakis, and E. P. Diamandis
Functional Roles of Human Kallikrein-related Peptidases
J. Biol. Chem., November 27, 2009; 284(48): 32989 - 32994.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wei, M. Fujita, M. Nakai, M. Waragai, K. Watabe, H. Akatsu, E. Rockenstein, E. Masliah, and M. Hashimoto
Enhanced Lysosomal Pathology Caused by beta-Synuclein Mutants Linked to Dementia with Lewy Bodies
J. Biol. Chem., September 28, 2007; 282(39): 28904 - 28914.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. Li, C. Lesuisse, Y. Xu, J. C. Troncoso, D. L. Price, and M. K. Lee
Stabilization of {alpha}-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation
J. Neurosci., August 18, 2004; 24(33): 7400 - 7409.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.